Pediatric liver transplantation with cadaveric or living related donors: Comparative results in 90 elective recipients of primary grafts

被引:131
作者
Reding, R
de Goyet, JD
Delbeke, I
Sokal, E
Jamart, J
Janssen, M
Otte, JB
机构
[1] Univ Louvain, Sch Med, Clin Univ St Luc, Dept Surg 1401,Pediat Liver Transplant Program, B-1200 Brussels, Belgium
[2] Mt Godinne Univ Hosp, Ctr Biostat & Med Documentat, Yvoir, Belgium
关键词
D O I
10.1016/S0022-3476(99)70450-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Study design: Between July 1993 and March 1997, 110 children were listed for primary elective liver transplantation with cadaveric (Cad: n = 68) or living-related (LR: n = 42) donors. Pregraft mortality, post-transplant survival, and surgical and immunologic complications were retrospectively compared in both groups. Results: The pregraft mortality rate was 10 (15%) of 68 versus 1 (2%) of 42 in the Cad and LR groups, respectively (P = .049). Post-liver transplantation 1-year patient and graft survival rates were 87% and 75% in the Cad group (n = 49) versus 92% and 90% in the LR group (n = 41), respectively (NS). The incidence of post-transplant complications was as follows: hepatic artery thrombosis (Cad: 16%; LR: 0%, P = .020), portal vein thrombosis (Cad: 8%; LR: 2%, NS), and biliary complications (Cad: 14%; LR: 34%, P = .044). The overall incidence of acute rejection was similar in both groups; however, a lower incidence of acute rejection occurred in LR graft recipients treated with tacrolimus. Conclusions: The introduction of an LR donor liver transplantation program allowed a significant decrease in the pretransplant mortality rate, with a consequent overall improvement in patient survival compared with the Cad series. The incidence of biliary complications was higher in the LR series, whereas better human leukocyte antigen matching in this subgroup did not result in a lower rejection incidence.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 19 条
  • [1] Allograft rejection in pediatric recipients of living related liver transplants
    Alonso, EM
    Piper, JB
    Echols, G
    Thistlethwaite, JR
    Whitington, PF
    [J]. HEPATOLOGY, 1996, 23 (01) : 40 - 43
  • [2] CALMUS Y, 1990, TRANSPLANT P, V22, P2311
  • [3] DAVIES HFS, 1989, TRANSPLANTATION, V47, P524
  • [4] IMPACT OF INNOVATIVE TECHNIQUES ON THE WAITING LIST AND RESULTS IN PEDIATRIC LIVER-TRANSPLANTATION
    DEGOYET, JD
    HAUSLEITHNER, V
    REDING, R
    LERUT, J
    JANSSEN, M
    OTTE, JB
    [J]. TRANSPLANTATION, 1993, 56 (05) : 1130 - 1136
  • [5] IMPROVED RESULTS OF LIVING-RELATED LIVER-TRANSPLANTATION WITH ROUTINE APPLICATION IN A PEDIATRIC PROGRAM
    EMOND, JC
    HEFFRON, TG
    KORTZ, EO
    GONZALEZVALLINA, R
    CONTIS, JC
    BLACK, DD
    WHITINGTON, PF
    MAKOWKA
    ILDSTAD
    [J]. TRANSPLANTATION, 1993, 55 (04) : 835 - 840
  • [6] GUNSON BK, 1992, TRANSPLANT P, V24, P2434
  • [7] The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation
    Inomata, Y
    Tanaka, K
    Egawa, H
    Uemoto, S
    Ozaki, N
    Okajima, H
    Satomura, K
    Kiuchi, T
    Yamaoka, Y
    Hashida, T
    [J]. TRANSPLANTATION, 1996, 61 (02) : 247 - 252
  • [8] KATZ SM, 1994, TRANSPLANT P, V26, P145
  • [9] CHOOSING A PEDIATRIC RECIPIENT FOR ORTHOTOPIC LIVER-TRANSPLANTATION
    MALATACK, JJ
    SCHAID, DJ
    URBACH, AH
    GARTNER, JC
    ZITELLI, BJ
    ROCKETTE, H
    FISCHER, J
    STARZL, TE
    IWATSUKI, S
    SHAW, BW
    [J]. JOURNAL OF PEDIATRICS, 1987, 111 (04) : 479 - 489
  • [10] MARKUS BH, 1988, TRANSPLANTATION, V46, P372